Short Term Trading New Year: 27 Dec - 1 Jan, page-80

PCK is making good commercial progress, and sent a nice Christmas update to their shareholders without an accompanying ASX announcement.

https://hotcopper.com.au/threads/painchek-general-discussion.4016359/page-1717?post_id=36937865

It is experiencing some "mind the gap" anxiety as people focus less on its global growth appeal and instead on the distance still to go before it becomes cash flow positive. This is a quality health technology growth stock with good execution from an ex Cochlear executive, but also beware the dilution risk.

It has a history of putting in big moves and not holding the gains. Thus far a good trader not a keeper, but I think this will change once the market sees the annuity income stream they are building and some visibility of the growth potential with progress in overseas sales and the Kids version of their facial recognition pain management product.